eCite Digital Repository

Coronavirus Disease-19: An interim evidence synthesis of the world association for infectious diseases and immunological disorders (Waidid)

Citation

Abu-Raya, B and Migliori, GB and O'Ryan, M and Edwards, K and Torres, A and Alffenaar, JW and Martson, AG and Centis, R and D'Ambrosio, L and Flanagan, K and Hung, I and Lauretani, F and Leung, CC and Leuridan, E and Maertens, K and Maggio, MG and Nadel, S and Hens, N and Niesters, H and Osterhaus, A and Pontali, E and Rossato Silva, D and Omer, S and Spanevello, A and Sverzellati, N and Tan, T and Torres-Torreti, JP and Visca, D and Esposito, S, Coronavirus Disease-19: An interim evidence synthesis of the world association for infectious diseases and immunological disorders (Waidid), Frontiers in Medicine, 7 pp. 1-20. ISSN 2296-858X (2020) [Refereed Article]


Preview
PDF
Not available
2Mb
  

DOI: doi:10.3389/fmed.2020.572485

Abstract

Coronavirus disease 2019 (COVID-19) is a rapidly evolving, highly transmissible, and potentially lethal pandemic caused by a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). As of June 11 2020, more than 7,000,000 COVID-19 cases have been reported worldwide, and more than 400,000 patients have died, affecting at least 188 countries. While literature on the disease is rapidly accumulating, an integrated, multinational perspective on clinical manifestations, immunological effects, diagnosis, prevention, and treatment of COVID-19 can be of global benefit. We aimed to synthesize the most relevant literature and experiences in different parts of the world through our global consortium of experts to provide a consensus-based document at this early stage of the pandemic.

Item Details

Item Type:Refereed Article
Keywords:COVID-19, SARS-CoV-2, coronavirus, infection control, intensive care management, physical distancing, prevention, workplace safety
Research Division:Biomedical and Clinical Sciences
Research Group:Immunology
Research Field:Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Objective Division:Health
Objective Group:Clinical health
Objective Field:Prevention of human diseases and conditions
UTAS Author:Flanagan, K (Dr Katie Flanagan)
ID Code:151636
Year Published:2020
Web of Science® Times Cited:10
Deposited By:Medicine
Deposited On:2022-08-02
Last Modified:2022-08-02
Downloads:0

Repository Staff Only: item control page